Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GTH Genetron (GTH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Genetron Stock (NASDAQ:GTH) 30 days 90 days 365 days Advanced Chart Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Genetron alerts:Sign Up Key Stats Today's Range$4.02▼$4.0550-Day Range$3.85▼$4.0352-Week Range$2.08▼$4.05Volume412,600 shsAverage Volume51,662 shsMarket Capitalization$127.43 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGenetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.Read More… This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Receive GTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. Email Address GTH Stock News HeadlinesGenetron Holdings Limited: Genetron Health Announces Completion of Going Private TransactionMarch 29, 2024 | finanznachrichten.deGenetron Health Announces Completion of Going Private TransactionMarch 28, 2024 | globenewswire.comWhy buying gold might be a mistakeSomething strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.November 14, 2024 | DTI (Ad)Genetron Holdings Limited: Genetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | finanznachrichten.deGenetron Health Announces Shareholders’ Approval of Merger AgreementFebruary 21, 2024 | finance.yahoo.comGenetron Health Announces Shareholders' Approval of Merger AgreementFebruary 21, 2024 | globenewswire.comGenetron (NASDAQ: GTH)February 14, 2024 | fool.comGenetron Holdings Ltd. ADRFebruary 14, 2024 | wsj.comSee More Headlines GTH Stock Analysis - Frequently Asked Questions How were Genetron's earnings last quarter? Genetron Holdings Limited (NASDAQ:GTH) issued its earnings results on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.30. The firm earned $14.05 million during the quarter. Read the conference call transcript. When did Genetron's stock split? Shares of Genetron reverse split before market open on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. When did Genetron IPO? Genetron (GTH) raised $162 million in an initial public offering on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers. What other stocks do shareholders of Genetron own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genetron investors own include NVIDIA (NVDA), ServiceNow (NOW), Broadcom (AVGO), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META) and Arista Networks (ANET). Company Calendar Last Earnings5/23/2021Today11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolNASDAQ:GTH CUSIPN/A CIK1782594 Webwww.genetronhealth.com Phone86-10-5090-7500FaxN/AEmployees993Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$94.34 million Price / Sales1.35 Cash FlowN/A Price / Cash FlowN/A Book Value$2.63 per share Price / Book1.53Miscellaneous Outstanding Shares31,620,000Free FloatN/AMarket Cap$127.43 million OptionableNot Optionable Beta0.51 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:GTH) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetron Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.